Trial intelligence / Profile preview

Magnesium Sulphate vs Dexmedetomidine for Emergence Agitation in Nasal Surgery

NCT04531371Phase 1Unknown

Sponsor
South Valley University
Start
Jun 2020
Primary completion
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of dexmedetomidine in Emergence agitation (EA) (3 arms), sponsored by South Valley University. Primary endpoint: post operative emergence agitation at 1 hour. Status: unknown.

02

Drugs

dexmedetomidine
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on NCT04531371.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04531371.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call